関連文献

Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression.

Eur J Pharmacol. 2017PubMed

The protective effect of human atrial natriuretic peptide on renal damage during cardiac surgery.

J Anesth. 2016PubMed

The association between urinary liver-type fatty acid-binding protein and chronic kidney disease classification in HIV-infected Japanese patients.

Clin Exp Nephrol. 2016PubMed

Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study.

Cardiovasc Diabetol. 15(1): 76, 2016.PubMed

Renoprotective effect of the xanthine oxidoreductase inhibitor, Topiroxostat,on Adenine-Induced Renal Injury.

Am J Physiol Renal Physiol. 310(11):F1366-1376, 2016.PubMed

Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis rats.

Physiol Rep. 3(12), 2015.PubMed

Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease.

Scand J Clin Lab Invest. 75(5): 421-427, 2015.PubMed

Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?

Nephrology. 10(4):e0122212, 2015.PubMed

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.

Clin Exp Nephrol. 19(6): 1044-1053, 2015.PubMed

A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1.

Am J Physiol Renal Physiol. 305(12): F1796-1803, 2013.PubMed